Title:
抗ＴＭＥＭ−１８０抗体、抗がん剤、及びがんの検査方法
Document Type and Number:
Japanese Patent JP6958817
Kind Code:
B2
Abstract:
An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
Inventors:
Yasuhiro Matsumura
Masanori Yasunaga
Nobufumi Saijo
Shingo Hanaoka
Anzai Takahiro
Manabe Fumino
Masanori Yasunaga
Nobufumi Saijo
Shingo Hanaoka
Anzai Takahiro
Manabe Fumino
Application Number:
JP2018504493A
Publication Date:
November 02, 2021
Filing Date:
March 07, 2017
Export Citation:
Assignee:
National Cancer Research Center
Rin Laboratory Co., Ltd.
Rin Laboratory Co., Ltd.
International Classes:
C12N15/12; A61K39/395; A61P35/00; C07K16/28; C12Q1/00; G01N33/574
Foreign References:
| WO2014041185A2 | ||||
| WO2013094307A1 |
Attorney, Agent or Firm:
Seiji Ohno
Hiroshi Morita
Yuko Matsuniya
Umeda Shinsuke
Hiroshi Morita
Yuko Matsuniya
Umeda Shinsuke
Previous Patent: Injection nozzle of well cleaning equipment
Next Patent: Mutation of L1 protein of human papillomavirus type 58
Next Patent: Mutation of L1 protein of human papillomavirus type 58